Emerging Antibacterial Strategies with Application of Targeting Drug Delivery System and Combined Treatment

References

• Xiong MH, Li YJ, Bao Y, Yang XZ, Hu B, Wang J. Bacteria-responsive multifunctional nanogel for targeted antibiotic delivery. Adv Mater. 2012;24(46):6175–6180. doi:10.1002/adma.201202847
   PubMed Web of Science ®Google Scholar
• Ohta S. Molecular hydrogen as a novel antioxidant: overview of the advantages of hydrogen for medical applications. Methods Enzymol. 2015;555:289–317.
   PubMed Web of Science ®Google Scholar
• Hu CM, Fang RH, Wang KC, et al. Nanoparticle biointerfacing by platelet membrane cloaking. Nature. 2015;526(7571):118–121. doi:10.1038/nature15373
   PubMed Web of Science ®Google Scholar
• Thamphiwatana S, Gao W, Pornpattananangkul D, et al. Phospholipase A2-responsive antibiotic delivery via nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Mater Chem B Mater Biol Med. 2014;2(46):8201–8207. doi:10.1039/C4TB01110D
   PubMedGoogle Scholar
• Zheng K, Li K, Chang TH, Xie J, Chen PY. Synergistic antimicrobial capability of magnetically oriented graphene oxide conjugated with gold nanoclusters. Adv Funct Mater. 2019;29:46.
   Google Scholar
• Tezel BU, Akçelik N, Yüksel FN, Karatuğ NT, Akçelik M. Effects of sub-MIC antibiotic concentrations on biofilm production of Salmonella infantis. Biotechnol Biotechnol Equip. 2016;30(6):1184–1191. doi:10.1080/13102818.2016.1224981
   Web of Science ®Google Scholar
• Re ACS, Martins JF, Cunha-Filho M, Gelfuso GM, Aires CP, Gratieri T. New perspectives on the topical management of recurrent candidiasis. Drug Deliv Transl Res. 2021;11(4):1568–1585. doi:10.1007/s13346-021-00901-0
   PubMed Web of Science ®Google Scholar
• Si Y, Grazon C, Clavier G, et al. Rapid and accurate detection of Escherichia coli growth by fluorescent pH-sensitive organic nanoparticles for high-throughput screening applications. Biosens Bioelectron. 2016;75:320–327. doi:10.1016/j.bios.2015.08.028
   PubMed Web of Science ®Google Scholar
• Radovic-Moreno AF, Lu TK, Puscasu VA, Yoon CJ, Langer R, Farokhzad OC. Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics. ACS Nano. 2012;6(5):4279–4287. doi:10.1021/nn3008383
   PubMed Web of Science ®Google Scholar
• Wang B, Liu H, Wang Z, et al. A self-defensive antibacterial coating acting through the bacteria-triggered release of a hydrophobic antibiotic from layer-by-layer films. J Mater Chem B. 2017;5(7):1498–1506. doi:10.1039/C6TB02614A
   PubMedGoogle Scholar
• Zhuk I, Jariwala F, Attygalle AB, Wu Y, Libera MR, Sukhishvili SA. Self-defensive layer-by-layer films with bacteria-triggered antibiotic release. ACS Nano. 2014;8(8):7733–7745. doi:10.1021/nn500674g
   PubMed Web of Science ®Google Scholar
• Arif M, Dong QJ, Raja MA, Zeenat S, Chi Z, Liu CG. Development of novel pH-sensitive thiolated chitosan/PMLA nanoparticles for amoxicillin delivery to treat Helicobacter pylori. Mater Sci Eng C. 2018;83:17–24. doi:10.1016/j.msec.2017.08.038
   PubMed Web of Science ®Google Scholar
• Thamphiwatana S, Fu V, Zhu J, Lu D, Gao W, Zhang L. Nanoparticle-stabilized liposomes for pH-responsive gastric drug delivery. Langmuir. 2013;29(39):12228–12233. doi:10.1021/la402695c
   PubMed Web of Science ®Google Scholar
• Ferguson EL, Azzopardi E, Roberts JL, Walsh TR, Thomas DW. Dextrin-colistin conjugates as a model bioresponsive treatment for multidrug resistant bacterial infections. Mol Pharm. 2014;11(12):4437–4447. doi:10.1021/mp500584u
   PubMedGoogle Scholar
• Hirst D, German L, Duncan R. Dextrins as carriers for drug targeting: reproducible succinoylation as a means to introduce pendant groups. J Bioact Compat Polym. 2001;16(5):353–365. doi:10.1106/QBKY-E3VM-19K4-3GA5
   Google Scholar
• Hreczuk-Hirst D, Chicco D, German L, Duncan R. Dextrins as potential carriers for drug targeting: tailored rates of dextrin degradation by introduction of pendant groups. Int J Pharm. 2001;230(1–2):57–66. doi:10.1016/S0378-5173(01)00859-6
   PubMed Web of Science ®Google Scholar
• Xiong MH, Bao Y, Yang XZ, Wang YC, Sun B, Wang J. Lipase-sensitive polymeric triple-layered nanogel for “on-demand” drug delivery. J Am Chem Soc. 2012;134(9):4355–4362. doi:10.1021/ja211279u
   PubMed Web of Science ®Google Scholar
• London E. How bacterial protein toxins enter cells; the role of partial unfolding in membrane translocation. Mol Microbiol. 1992;6(22):3277–3282. doi:10.1111/j.1365-2958.1992.tb02195.x
   PubMedGoogle Scholar
• Menestrina G, Pederzolli C, Forti S, Gambale F. Lipid interaction of Pseudomonas aeruginosa exotoxin A. Acid-triggered permeabilization and aggregation of lipid vesicles. Biophys J. 1991;60(6):1388–1400. doi:10.1016/S0006-3495(91)82176-2
   PubMedGoogle Scholar
• Olsnes S, Sandvig K. How protein toxins enter and kill cells. Cancer Treat Res. 1988;37:39–73.
   PubMedGoogle Scholar
• Pornpattananangkul D, Zhang L, Olson S, et al. Bacterial toxin-triggered drug release from gold nanoparticle-stabilized liposomes for the treatment of bacterial infection. J Am Chem Soc. 2011;133(11):4132–4139. doi:10.1021/ja111110e
   PubMed Web of Science ®Google Scholar
• Yang S, Han X, Yang Y, et al. Bacteria-targeting nanoparticles with microenvironment-responsive antibiotic release to eliminate intracellular staphylococcus aureus and associated infection. ACS Appl Mater Interfaces. 2018;10(17):14299–14311. doi:10.1021/acsami.7b15678
   PubMed Web of Science ®Google Scholar
• Khin MM, Hua JS, Ng HC, Wadstrom T, Bow H. Agglutination of Helicobacter pylori coccoids by lectins. World J Gastroenterol. 2000;6(2):202–209.
   PubMedGoogle Scholar
• Umamaheshwari RB, Jain NK. Receptor mediated targeting of lectin conjugated gliadin nanoparticles in the treatment of Helicobacter pylori. J Drug Target. 2003;11(7):415–423; discussion 423–414. doi:10.1080/10611860310001647771
   PubMedGoogle Scholar
• Forier K, Raemdonck K, De Smedt SC, Demeester J, Coenye T, Braeckmans K. Lipid and polymer nanoparticles for drug delivery to bacterial biofilms. J Control Release. 2014;190:607–623. doi:10.1016/j.jconrel.2014.03.055
   PubMed Web of Science ®Google Scholar
• Sihorkar V, Vyas SP. Biofilm consortia on biomedical and biological surfaces: delivery and targeting strategies. Pharm Res. 2001;18(9):1247–1254. doi:10.1023/A:1013073508318
   PubMedGoogle Scholar
• Long Y, Li Z, Bi Q, et al. Novel polymeric nanoparticles targeting the lipopolysaccharides of Pseudomonas aeruginosa. Int J Pharm. 2016;502(1–2):232–241. doi:10.1016/j.ijpharm.2016.02.021
   PubMedGoogle Scholar
• Li L, Lu Y, Bie Z, Chen HY, Liu Z. Photolithographic boronate affinity molecular imprinting: a general and facile approach for glycoprotein imprinting. Angew Chem Int Ed. 2013;52(29):7451–7454. doi:10.1002/anie.201207950
   PubMed Web of Science ®Google Scholar
• Zeng Z, Hoshino Y, Rodriguez A, Yoo H, Shea KJ. Synthetic polymer nanoparticles with antibody-like affinity for a hydrophilic peptide. ACS Nano. 2010;4(1):199–204. doi:10.1021/nn901256s
   PubMedGoogle Scholar
• Pan G, Guo Q, Ma Y, Yang H, Li B. Thermo-responsive hydrogel layers imprinted with RGDS peptide: a system for harvesting cell sheets. Angew Chem Int Ed. 2013;52(27):6907–6911. doi:10.1002/anie.201300733
   PubMedGoogle Scholar
• Kang SJ, Park SJ, Mishig-Ochir T, Lee BJ. Antimicrobial peptides: therapeutic potentials. Expert Rev Anti Infect Ther. 2014;12(12):1477–1486. doi:10.1586/14787210.2014.976613
   PubMed Web of Science ®Google Scholar
• Mohtashamian S, Boddohi S. Nanostructured polysaccharide-based carriers for antimicrobial peptide delivery. J Pharmaceut Invest. 2017;47(2):85–94. doi:10.1007/s40005-016-0289-1
   Google Scholar
• Kim H, Jang JH, Kim SC, Cho JH. Enhancement of the antimicrobial activity and selectivity of GNU7 against Gram-negative bacteria by fusion with LPS-targeting peptide. Peptides. 2016;82:60–66. doi:10.1016/j.peptides.2016.05.010
   PubMedGoogle Scholar
• Braun V, Götz F, Schultz JE, Wohlleben W. The bacterial cell envelope: structure, function, and infection interface. Int J Med Microbiol. 2015;305(2):175–177. doi:10.1016/j.ijmm.2014.12.003
   PubMedGoogle Scholar
• Malanovic N, Lohner K. Gram-positive bacterial cell envelopes: the impact on the activity of antimicrobial peptides. Biochim Biophys Acta. 2016;1858(5):936–946. doi:10.1016/j.bbamem.2015.11.004
   PubMed Web of Science ®Google Scholar
• Ogundele MO. A novel anti-inflammatory activity of lysozyme: modulation of serum complement activation. Mediators Inflamm. 1998;7(5):363–365. doi:10.1080/09629359890893
   PubMed Web of Science ®Google Scholar
• Ibrahim HR. New drug-targeting strategy from beneath the shell of egg. Expert Opin Drug Deliv. 2010;7(10):1145–1158. doi:10.1517/17425247.2010.515208
   PubMed Web of Science ®Google Scholar
• Luo M, Jia YY, Jing ZW, et al. Construction and optimization of pH-sensitive nanoparticle delivery system containing PLGA and UCCs-2 for targeted treatment of Helicobacter pylori. Colloids Surf B Biointerfaces. 2018;164:11–19. doi:10.1016/j.colsurfb.2018.01.008
   PubMed Web of Science ®Google Scholar
• Jing ZW, Jia YY, Wan N, et al. Design and evaluation of novel pH-sensitive ureido-conjugated chitosan/TPP nanoparticles targeted to Helicobacter pylori. Biomaterials. 2016;84:276–285. doi:10.1016/j.biomaterials.2016.01.045
   PubMed Web of Science ®Google Scholar
• Fallon PG, Alcami A. Pathogen-derived immunomodulatory molecules: future immunotherapeutics? Trends Immunol. 2006;27(10):470–476. doi:10.1016/j.it.2006.08.002
   PubMedGoogle Scholar
• Alvarez-Lorenzo C, Garcia-Gonzalez CA, Bucio E, Concheiro A. Stimuli-responsive polymers for antimicrobial therapy: drug targeting, contact-killing surfaces and competitive release. Expert Opin Drug Deliv. 2016;13(8):1109–1119. doi:10.1080/17425247.2016.1178719
   PubMed Web of Science ®Google Scholar
• Sharma A, Kumar Arya D, Dua M, Chhatwal GS, Johri AK. Nano-technology for targeted drug delivery to combat antibiotic resistance. Expert Opin Drug Deliv. 2012;9(11):1325–1332. doi:10.1517/17425247.2012.717927
   PubMed Web of Science ®Google Scholar
• Mudakavi R, Vanamali S, Chakravortty D, Raichur A. Development of arginine based nanocarriers for targeting and treatment of intracellular Salmonella. RSC Adv. 2017;7(12):7022–7032. doi:10.1039/C6RA27868J
   Web of Science ®Google Scholar
• Chono S, Tanino T, Seki T, Morimoto K. Efficient drug targeting to rat alveolar macrophages by pulmonary administration of ciprofloxacin incorporated into mannosylated liposomes for treatment of respiratory intracellular parasitic infections. J Control Release. 2008;127(1):50–58. doi:10.1016/j.jconrel.2007.12.011
   PubMed Web of Science ®Google Scholar
• Sinha J, Mukhopadhyay S, Das N, Basu MK. Targeting of liposomal andrographolide to L. donovani-infected macrophages in vivo. Drug Deliv. 2000;7(4):209–213. doi:10.1080/107175400455137
   PubMedGoogle Scholar
• Chono S, Tanino T, Seki T, Morimoto K. Uptake characteristics of liposomes by rat alveolar macrophages: influence of particle size and surface mannose modification. J Pharm Pharmacol. 2007;59(1):75–80. doi:10.1211/jpp.59.1.0010
   PubMed Web of Science ®Google Scholar
• Nimje N, Agarwal A, Saraogi GK, et al. Mannosylated nanoparticulate carriers of rifabutin for alveolar targeting. J Drug Target. 2009;17(10):777–787. doi:10.3109/10611860903115308
   PubMed Web of Science ®Google Scholar
• Chono S, Kaneko K, Yamamoto E, Togami K, Morimoto K. Effect of surface-mannose modification on aerosolized liposomal delivery to alveolar macrophages. Drug Dev Ind Pharm. 2010;36(1):102–107. doi:10.3109/03639040903099744
   PubMed Web of Science ®Google Scholar
• Lee WH, Loo CY, Traini D, Young PM. Nano- and micro-based inhaled drug delivery systems for targeting alveolar macrophages. Expert Opin Drug Deliv. 2015;12(6):1009–1026. doi:10.1517/17425247.2015.1039509
   PubMed Web of Science ®Google Scholar
• de Steenwinkel JE, van Vianen W, Ten Kate MT, et al. Targeted drug delivery to enhance efficacy and shorten treatment duration in disseminated Mycobacterium avium infection in mice. J Antimicrob Chemother. 2007;60(5):1064–1073. doi:10.1093/jac/dkm341
   PubMed Web of Science ®Google Scholar
• Woodle MC. Sterically stabilized liposome therapeutics. Adv Drug Deliv Rev. 1995;16(2):249–265. doi:10.1016/0169-409X(95)00028-6
   Google Scholar
• Zhang J, Xie L, Xu D, et al. Targeting expression of antimicrobial peptide CAMA-Syn by adenovirus vector in macrophages inhibits the growth of intracellular bacteria. Gene. 2017;630:59–67. doi:10.1016/j.gene.2017.07.079
   PubMedGoogle Scholar
• Hajipour MJ, Fromm KM, Ashkarran AA, et al. Antibacterial properties of nanoparticles. Trends Biotechnol. 2012;30(10):499–511. doi:10.1016/j.tibtech.2012.06.004
   PubMed Web of Science ®Google Scholar
• Gupta A, Landis RF, Rotello VM. Nanoparticle-based antimicrobials: surface functionality is critical. F1000Research. 2016;5:1–10. doi:10.12688/f1000research.7595.1
   Google Scholar
• Miller KP, Wang L, Benicewicz BC, Decho AW. Inorganic nanoparticles engineered to attack bacteria. Chem Soc Rev. 2015;44(21):7787–7807.
   PubMed Web of Science ®Google Scholar
• Jones MN, Song YH, Kaszuba M, Reboiras MD. The interaction of phospholipid liposomes with bacteria and their use in the delivery of bactericides. J Drug Target. 1997;5(1):25–34. doi:10.3109/10611869708995855
   PubMed Web of Science ®Google Scholar
• Jones MN, Kaszuba M, Hill KJ, Song YH, Creeth JE. The use of phospholipid liposomes for targeting to oral and skin-associated bacteria. J Drug Target. 1994;2(5):381–389. doi:10.3109/10611869408996813
   PubMed Web of Science ®Google Scholar
• Jones MN, Kaszuba M, Reboiras MD, et al. The targeting of phospholipid liposomes to bacteria. Biochim Biophys Acta. 1994;1196(1):57–64. doi:10.1016/0005-2736(94)90295-X
   PubMed Web of Science ®Google Scholar
• Wang Y, Ding X, Chen Y, et al. Antibiotic-loaded, silver core-embedded mesoporous silica nanovehicles as a synergistic antibacterial agent for the treatment of drug-resistant infections. Biomaterials. 2016;101:207–216. doi:10.1016/j.biomaterials.2016.06.004
   PubMed Web of Science ®Google Scholar
• Huh AJ, Kwon YJ. “Nanoantibiotics”: a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release. 2011;156(2):128–145.
   PubMed Web of Science ®Google Scholar
• Blecher K, Nasir A, Friedman A. The growing role of nanotechnology in combating infectious disease. Virulence. 2011;2(5):395–401. doi:10.4161/viru.2.5.17035
   PubMed Web of Science ®Google Scholar
• Christofferson AJ, Elbourne A, Cheeseman S, et al. Conformationally tuned antibacterial oligomers target the peptidoglycan of gram-positive bacteria. J Colloid Interface Sci. 2020;580:850–862. doi:10.1016/j.jcis.2020.07.090
   PubMedGoogle Scholar
• Im BN, Shin H, Lim B, et al. Helicobacter pylori-targeting multiligand photosensitizer for effective antibacterial endoscopic photodynamic therapy. Biomaterials. 2021;271:120745. doi:10.1016/j.biomaterials.2021.120745
   PubMed Web of Science ®Google Scholar
• Pan WY, Huang CC, Lin TT, et al. Synergistic antibacterial effects of localized heat and oxidative stress caused by hydroxyl radicals mediated by graphene/iron oxide-based nanocomposites. Nanomedicine. 2016;12(2):431–438. doi:10.1016/j.nano.2015.11.014
   PubMed Web of Science ®Google Scholar
• Jaque D, Martínez Maestro L, Del Rosal B, et al. Nanoparticles for photothermal therapies. Nanoscale. 2014;6(16):9494–9530.
   PubMed Web of Science ®Google Scholar
• Xu JW, Yao K, Xu ZK. Nanomaterials with a photothermal effect for antibacterial activities: an overview. Nanoscale. 2019;11(18):8680–8691. doi:10.1039/C9NR01833F
   PubMed Web of Science ®Google Scholar
• Ding X, Yuan P, Gao N, Zhu H, Yy Y, Qh X. Au-Ag core-shell nanoparticles for simultaneous bacterial imaging and synergistic antibacterial activity. Nanomedicine. 2017;13(1):297–305. doi:10.1016/j.nano.2016.09.003
   PubMedGoogle Scholar
• Xu X, Liu X, Tan L, et al. Controlled-temperature photothermal and oxidative bacteria killing and acceleration of wound healing by polydopamine-assisted Au-hydroxyapatite nanorods. Acta Biomater. 2018;77:352–364. doi:10.1016/j.actbio.2018.07.030
   PubMed Web of Science ®Google Scholar
• Li L, Liu Y, Hao P, et al. PEDOT nanocomposites mediated dual-modal photodynamic and photothermal targeted sterilization in both NIR I and II window. Biomaterials. 2015;41:132–140. doi:10.1016/j.biomaterials.2014.10.075
   PubMed Web of Science ®Google Scholar
• Qiu WZ, Yang HC, Xu ZK. Dopamine-assisted co-deposition: an emerging and promising strategy for surface modification. Adv Colloid Interface Sci. 2018;256:111–125. doi:10.1016/j.cis.2018.04.011
   PubMed Web of Science ®Google Scholar
• Liu D, Ma L, Liu L, et al. Polydopamine-encapsulated Fe3O4 with an adsorbed HSP70 inhibitor for improved photothermal inactivation of bacteria. ACS Appl Mater Interfaces. 2016;8(37):24455–24462. doi:10.1021/acsami.6b08119
   PubMedGoogle Scholar
• Yu L, Luo B, Li Z, He J, Lan F, Wu Y. PAMAM-PMAA brush-functionalized magnetic composite nanospheres: a smart nanoprobe with tunable selectivity for effective enrichment of mono-, multi-, or global phosphopeptides. J Mater Chem B. 2020;8(6):1266–1276. doi:10.1039/C9TB02577D
   PubMed Web of Science ®Google Scholar
• Meeker DG, Jenkins SV, Miller EK, et al. Synergistic photothermal and antibiotic killing of biofilm-associated staphylococcus aureus using targeted antibiotic-loaded gold nanoconstructs. ACS Infect Dis. 2016;2(4):241–250. doi:10.1021/acsinfecdis.5b00117
   PubMedGoogle Scholar
• Zhao Y, Dai X, Wei X, et al. Near-infrared light-activated thermosensitive liposomes as efficient agents for photothermal and antibiotic synergistic therapy of bacterial biofilm. ACS Appl Mater Interfaces. 2018;10(17):14426–14437. doi:10.1021/acsami.8b01327
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Wang J, et al. Photon-responsive antibacterial nanoplatform for synergistic photothermal-/pharmaco-therapy of skin infection. ACS Appl Mater Interfaces. 2019;11(1):300–310. doi:10.1021/acsami.8b18146
   PubMed Web of Science ®Google Scholar